CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) -- a common condition, ...
Integrating a rapid point-of-care polymerase chain reaction (PCR) testing for sexually transmitted infections (STIs) in the emergency department (ED) reduced the length of stay of patients by 76 ...
CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered into a definitive asset purchase ...
Lumos Diagnostics (ASX:LDX) has announced that the US Food and Drug Administration (FDA) has granted a Clinical Laboratory ...
Lumos Diagnostics Holdings Ltd (ASX:LDX), a company specialising in rapid, point-of-care diagnostic test technology, ...
Lumos completes US$14 million ($20m) placement to institutional investors to support US rollout of FebriDX ... Read More The ...
Point-of-care testing for group A beta-hemolytic Streptococcus (Strep A) significantly reduced antibiotic prescriptions in children and adults with signs of pharyngitis, even when used as the sole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results